Unavailable Treatments

Unfortunately, treatments and over-the-counter products occasionally become unavailable for a variety of reasons.

See below for updates on the unavailable treatments that we are aware of, but please do get in touch with us if you become aware of an issue that is not listed below. We are not always contacted by treatment manufacturers when there is an availability concern, and so we do rely on the information of our supporters.

Clarelux Foam

In January 2020, Pierre Fabre Dermo-Cosmetique, the manufacturer of topical corticosteroid treatment, Clarelux foam, contacted us with an update on the availability of the product.

They confirmed that stocks of the product, which were expected to return to pharmacies in January 2020, have been delayed, and they do not know when Clarelux will return to stock.

If you have any questions or would like further information, the manufacturer can be contacted directly either by phone on 0208 731 3322, or by email at medicalinformation@pierre-fabre.co.uk.

Alphosyl 2 in 1 Medicated Shampoo

We contacted Omega Pharma Ltd, the Market Authorisation Holder of Alphosyl 2 in 1 Medicated Shampoo, in early January 2020 following enquiries about product availability.

Omega confirmed that they are currently experiencing supply issues with the coal-tar based shampoo. They told us that Alphosyl is expected to return to market by the end of February 2020.

If you have any questions or would like further information, you can contact Omega Pharma by phone on +44 (0) 203 598 9603 (Customer Care) or email at UKLOcustomerservice@perrigo.com  (medical information).

Exorex Moisturising Cream

In early January 2020 we contacted Teva UK Limited, the manufacturer of Exorex Moisturising Cream, to ask for an update following a recent enquiry regarding availability issues with the product.

Teva UK confirmed that Exorex Moisturising Cream is currently unavailable in both 100g and 250g sizes due to a manufacturing delay. They said that the product should be back in stock by the end of February 2020.

Please note that this update refers to Exorex Moisturising Cream only, there are no issues with the availability of Exorex Lotion.

If you have any questions or would like further information, the manufacturer can be contacted directly either by phone on 0800 590 502 (stock availability), or by email at medinfo@tevauk.com  (medical information).

Bettamousse Foam

Following ongoing availability issues with Bettamousse 0.1% Cutaneous Foam (betamethasone valerate)  the manufacturer of Bettamousse, RPH Pharmaceuticals AB, contacted us with an update in December 2019.

RPH confirmed that there have been delays with the delivery of Bettamousse Foam, which they were due to receive near the end of November. According to this latest update Bettamousse is expected to return to stock in January 2020.

If you have any questions or would like further information, the manufacturer can be contacted directly either by phone on 0845 023 0467, or by email at customer.care@recipharm,com.  

Ceanel Shampoo

In August 2019, we contacted Alliance Pharmaceuticals, manufacturer of the medicated scalp shampoo, Ceanel Concentrate, for an update on the availability of the product. They confirmed that Ceanel is currently out of production and they do not yet have a date for when it may return.

In the meantime, Alliance Pharma recommends that anyone affected by the unavailability of Ceanel Shampoo discusses suitable alternatives with their GP or Pharmacist.

If you have any questions or would like further information, the manufacturer can be contacted directly either by phone on 01249 466 966, or by email at medinfo@alliancepharma.co.uk. 

Aquamol Emollient Cream

Thornton and Ross Ltd have announced they are withdrawing Aquamol Emollient Cream from manufacture due to poor demand for the product. They told the Psoriasis Association 'the minimum volumes that we have to produce on a production run are far higher than demand and as such it wasn't viable to continue producing the product'.

If anyone has any questions, or would like to know more you can get in touch with the manufacturer directly either by phone on 01484 848 164, or by email at thorntonross@medinformation.co.uk.

We advise anyone affected by the discontinuation of Aquamol Emollient Cream to speak to their GP about alternative emollients that are available.

Dovobet Gel Applicator

Dovobet Gel Applicator (website news) 1LEO Pharma has announced plans to phase out its Dovobet Gel (calcipotriol/betamethasone dipropionate gel) applicator from the beginning of summer 2019 in the UK, and autumn 2019 in Ireland, or earlier as and when existing stocks are depleted. This decision has been taken due to a lack of demand for the applicator. Please note that Dovobet Gel will remain available in bottles.

LEO apologises for any inconvenience caused by this product discontinuation, and recommends that anybody affected visits their healthcare professional to discuss their individual needs and preferences for the management of their psoriasis.

If you have any questions or would like further information, the manufacturer can be contacted directly either by phone on 01844 347 333, or by email at medical-info.uk@leo-pharma.com if you are in the UK.

If you are based in Ireland, you can reach LEO Pharma's Medical Information team either by phone on +353 1 490 89, or by email at medical-info.ie@leo-pharma.com.

The Psoriasis Association is the UK's leading national charity and membership organisation for people affected by psoriasis – patients, families, carers and health professionals Read More >

Get in touch

The Psoriasis Association Dick Coles House 2 Queensbridge Northampton NN4 7BF

Email: mail@psoriasis-association.org.uk

Tel :
01604 251 620
WhatsApp :
07387716439
Registered with Fundraising Regulator -

© The Psoriasis Association Charitable Incorporated Organisation Number: 1180666 Scotland: SC049563 Privacy PolicyCookies

Site by Spoken Image | glitterfish

We use cookies to help us provide you with a better service, but do not track anything that can be used to personally identify you.

If you prefer us not to set these cookies, please visit our Cookie Settings page or continue browsing our site to accept them.